Authors’ reply to letters to the editor “model-based simulation to support the extended dosing regimens of atezolizumab”

研究成果: Letter › 同行評審

原文	English
頁（從 - 到）	1067-1068
頁數	2
期刊	European Journal of Clinical Pharmacology
卷	77
發行號	7
DOIs	https://doi.org/10.1007/s00228-020-03055-z
出版狀態	Published - 2021 7月

All Science Journal Classification (ASJC) codes

@article{c74a077a96b541439a74e2829f4eb1ed,

title = "Authors{\textquoteright} reply to letters to the editor “model-based simulation to support the extended dosing regimens of atezolizumab”",

author = "Chou, {Chen Hsi} and Hsu, {Li Feng}",

year = "2021",

month = jul,

doi = "10.1007/s00228-020-03055-z",

language = "English",

volume = "77",

pages = "1067--1068",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

publisher = "Springer Verlag",

number = "7",

}

TY - JOUR

T1 - Authors’ reply to letters to the editor “model-based simulation to support the extended dosing regimens of atezolizumab”

AU - Chou, Chen Hsi

AU - Hsu, Li Feng

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85096593269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096593269&partnerID=8YFLogxK

U2 - 10.1007/s00228-020-03055-z

DO - 10.1007/s00228-020-03055-z

M3 - Letter

C2 - 33237384

AN - SCOPUS:85096593269

SN - 0031-6970

VL - 77

SP - 1067

EP - 1068

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

IS - 7

ER -